Increasing the Performance of a Fully Automated Quantitative Assay for the Detection of Circulating HBV Pregenomic RNA
(presented at 2022 Digestive Disease Week in San Diego, CA.) Summary: A presentation of the increased analytical performance of a fully automated assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
Cerebrospinal fluid CXCL10 is associated with the presence of low-level CSF HIV during suppressive antiretroviral therapy
(Journal of Neuroimmunology 2021, 353:577493) Cerebrospinal fluid CXCL10 is associated with the presence of low-level CSF HIV during suppressive antiretroviral therapy.
Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
(JAIDS 2021, 87(5):1196-1204) Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
Increasing the performance of a fully automated quantitative assay for the detection of circulating HBV pregenomic RNA
(presented at 2021 HEP DART in Los Cabos, Mexico) Summary: A presentation of the increased analytical performance of a fully automated assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
Hepatitis B pregenomic RNA: Performance of an Automated Real-Time Quantitative Assay
(presented at 2019 CVS in Savannah, GA) Summary: A presentation of the analytical performance of a new assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
Hepatitis B Pregenomic RNA Real-Time Quantitative Assay for Drug Development
(presented at 2019 HEP DART in Kauai, Hawaii.) Summary: A presentation of the analytical performance of a new assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
Prevelence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy
(The Journal of Infectious Diseases 2017, 215:105-13) Summary: bioMONTR Labs’ proprietary HIV-1 SuperLow Assay was utilized to measure HIV-1 RNA levels in CSF and plasma from adults taking suppressive ART to assess if the association between HIV-1 RNA discordance and HAND may reflect compartmentalization.
Validation of eMAG™ for HIV-1 Low Viremia Testing
(Presented at 2017 CVS in Savannah, GA) Summary: A presentation of the validation for using the eMAG with bioMONTR Labs’ HIV-1 SuperLow assay, a RESEARCH USE ONLY for detection of single copy HIV-1 RNA.
Full Automation and Flexibility for Extraction of Free Circulating Nucleic Acids: Proof of Concept for eMAG™
(Presented at 2017 CVS in Savannah, GA) Summary: This study evaluated the use of eMAG for fully automated extraction of free circulating nucleic acids.
Workflow Optimization of the ViroSeq™ Human Immunodeficiency Virus-1 (HIV-1) Genotyping System
(Hum Virol Retrovirol 2015, 2(7); 00071) Summary: The study evaluated workflow organization and automation improvements to the ViroSeq HIV-1 Genotyping System through the use of semi-automated extraction platforms, automated amplicon quantification, and high-throughput sequencing platforms.